Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
paper
Cited
Public
Unavailable
- Authors
- Bond, C; LaForge, K S; Tian, M; Melia, D; Zhang, S; Borg, L; Gong, J; Schluger, J; Strong, J A; Leal, S M; Tischfield, J A; Kreek, M J; Yu, L
- Year
- 1998
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 9689128
- DOI
- 10.1073/pnas.95.16.9608
- PMCID
- PMC21386
Opioid drugs play important roles in the clinical management of pain, as well as in the development and treatment of drug abuse. The mu opioid receptor is the primary site of action for the most commonly used opioids, including morphine, heroin, fentanyl, and methadone. By sequencing DNA from 113 former heroin addicts in methadone maintenance and 39 individuals with no history of drug or alcohol abuse or dependence, we have identified five different single-nucleotide polymorphisms (SNPs) in the coding region of the mu opioid receptor gene. The most prevalent SNP is a nucleotide substitution at position 118 (A118G), predicting an amino acid change at a putative N-glycosylation site. This SNP displays an allelic frequency of approximately 10% in our study population. Significant differences in allele distribution were observed among ethnic groups studied. The variant receptor resulting from the A118G SNP did not show altered binding affinities for most opioid peptides and alkaloids tested. However, the A118G variant receptor binds beta-endorphin, an endogenous opioid that activates the mu opioid receptor, approximately three times more tightly than the most common allelic form of the receptor. Furthermore, beta-endorphin is approximately three times more potent at the A118G variant receptor than at the most common allelic form in agonist-induced activation of G protein-coupled potassium channels. These results show that SNPs in the mu opioid receptor gene can alter binding and signal transduction in the resulting receptor and may have implications for normal physiology, therapeutics, and vulnerability to develop or protection from diverse diseases including the addictive diseases.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Pharmacogenetic Predictors of Postoperative Opioid-Related Adverse Events: A Systematic Review. | KjartansdΓ³ttir SP et al. | β | 2026 | β |
| A review of the existing pharmacogenomic literature of naltrexone for use in alcohol use disorder. | Counts C et al. | β | 2025 | β |
| Association of endogenous hormones with major depressive disorder phenotype: A systematic review and meta-analysis of drug-free case and control cross-sectional study. | Machahary N et al. | β | 2025 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Buprenorphine and norbuprenorphine concentrations associated with clinical withdrawal during pregnancy. | Caritis SN et al. | β | 2025 | β |
| De novo post-COVID-19 chronic pain: a piece of information about risk factor and clinical features. | Goncalves FT et al. | β | 2025 | β |
| Genetic and Epigenetic Approaches to Opioid Use Disorder. | Ranadeva ND et al. | β | 2025 | β |
| Genetic Variation A118G in the OPRM1 Gene Underlies the Dimorphic Response to Epidural Opioid-Induced Itch. | Zhou X et al. | β | 2025 | β |
| How does neurochemistry affect attachment styles in humans? The role of oxytocin and the endogenous opioid system in sociotropy and autonomy - A systematic review. | Snowdon-Farrell A et al. | β | 2025 | β |
| Molecular and cellular basis of mu-opioid receptor signaling: mechanisms underlying tolerance and dependence development. | Swingler M et al. | β | 2025 | β |
| Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses. | Skeete C et al. | β | 2025 | β |
| Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks. | Agarwal U et al. | β | 2025 | β |
| Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study. | Juya F et al. | β | 2025 | β |
| Pharmacogenetics of opioid medications for relief of labor pain and post-cesarean pain: a systematic review and meta-analysis. | Giacon M et al. | β | 2025 | β |
| Similarities and Differences in Genetics. | Liu W et al. | β | 2025 | β |
| The influence of genetic and epigenetic variations on dynamic experimental pain measures in adults with and without chronic musculoskeletal pain: a systematic review. | Billens A et al. | β | 2025 | β |
| Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study. | Takemura M et al. | β | 2024 | β |
| Effects of functional polymorphisms of opioid receptor mu 1 and catechol-O-methyltransferase on the neural processing of pain. | Cheong Y et al. | β | 2024 | β |
| Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice-variant andΒ agonist-specific recruitment of Ξ²-arrestin. | Patrick C et al. | β | 2024 | β |
| Introduction: Approved treatments for alcohol use disorder by regulatory agencies. | Camarini R et al. | β | 2024 | β |
| Ketamine: Mechanisms and Relevance to Treatment of Depression. | Kim JW et al. | β | 2024 | β |
| Molecular and Environmental Determinants of Addictive Substances. | Lorek M et al. | β | 2024 | β |
| Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome. | Duffy EP et al. | β | 2024 | β |
| Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment. | Dunn KE et al. | β | 2024 | β |
| Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response. | Anghel SA et al. | β | 2024 | β |
| 5. Collaborative Study on the Genetics of Alcoholism: Functional genomics. | Gameiro-Ros I et al. | β | 2023 | β |
| Allele frequency and genotype distribution of the opioid receptor ΞΌ-1 (OPRM1) A118G polymorphism in the Western Saudi population. | Bagher AM et al. | β | 2023 | β |
| Association between opioid and dopamine receptor gene polymorphisms OPRM1 rs1799971, DAT VNTR 9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analysis. | Suresh N et al. | β | 2023 | β |
| Association of Genetic Variants with Postsurgical Pain: A Systematic Review and Meta-analyses. | Frangakis SG et al. | β | 2023 | β |
| Genetic and epigenetic effects on couple adjustment in context of romantic relationship: A scoping systematic review. | Khani P et al. | β | 2023 | β |
| Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study. | Kumar S et al. | β | 2023 | β |
| Intervertebral disc degeneration and how it leads to low back pain. | Diwan AD et al. | β | 2023 | β |
| Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Blum K et al. | β | 2023 | β |
| Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients. | Kong L et al. | β | 2023 | β |
| Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. | AgullΓ³ L et al. | β | 2023 | β |
| The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder. | Margolis EB et al. | β | 2023 | β |
| Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors? | FernΓ‘ndez-de-Las-PeΓ±as C et al. | β | 2022 | β |
| Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. | Xie X et al. | β | 2022 | β |
| Association of the D-amino acid oxidase gene with methadone dose in heroin dependent patients under methadone maintenance treatment. | Liu TH et al. | β | 2022 | β |
| Dysregulated expression of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in the medial prefrontal cortex of male human heroin abusers and heroin self-administering male rats. | Brown TG et al. | β | 2022 | β |
| Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial. | Schacht JP et al. | β | 2022 | β |
| Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor Β΅1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? | GondrΓ©-Lewis MC et al. | β | 2022 | β |
| Genetic polymorphisms of <i>OPRM1</i> on the efficacy and safety of anesthetic and analgesic agents: a systematic review. | Yee L et al. | β | 2022 | β |
| Genetic Variants Associated With Resilience in Human and Animal Studies. | Cahill S et al. | β | 2022 | β |
| <i>ABCB1</i> and <i>OPRM1</i> single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors. | Firfirey F et al. | β | 2022 | β |
| Mu opioid receptor gene variant modulates subjective response to smoked cannabis. | Bourgault Z et al. | β | 2022 | β |
| Nicotine and opioid co-dependence: Findings from bench research to clinical trials. | Custodio L et al. | β | 2022 | β |
| Part I: Missouri's Fentanyl Poisonings Rise to Record Levels. | Stoecker WV et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| Rapid detection of single nucleotide polymorphisms using the MinION nanopore sequencer: a feasibility study for perioperative precision medicine. | Tabata Y et al. | β | 2022 | β |
| Shared Genetic Regulatory Networks Contribute to Neuropathic and Inflammatory Pain: Multi-Omics Systems Analysis. | Ye F et al. | β | 2022 | β |
| Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer. | Baker Rogers J et al. | β | 2022 | β |
| Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder. | Kaya-AkyΓΌzlΓΌ D et al. | β | 2022 | β |
| The A118G single-nucleotide polymorphism in OPRM1 is a risk factor for asthma severity. | Kawakami K et al. | β | 2022 | β |
| The OPRM1 gene and interactions with the 5-HT1a gene regulate conditioned pain modulation in fibromyalgia patients and healthy controls. | Tour J et al. | β | 2022 | β |
| Variation in the Mu-Opioid Receptor (OPRM1) and Offspring Sex Are Associated With Maternal Behavior in Rhesus Macaques (<i>Macaca mulatta</i>). | Wood EK et al. | β | 2022 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Developmental Considerations for the Use of Naltrexone in Children and Adolescents. | Stancil SL et al. | β | 2021 | β |
| Effect of Chaihu-jia-Longgu-Muli decoction on withdrawal symptoms in rats with methamphetamine-induced conditioned place preference. | Li Z et al. | β | 2021 | β |
| Epigenetic and Genetic Factors Associated With Opioid Use Disorder: Are These Relevant to African American Populations. | Blackwood CA et al. | β | 2021 | β |
| [Genetics and pain: approach and implications in clinical practice]. | Montero AA et al. | β | 2021 | β |
| Genetic variants in levodopa-induced dyskinesia (LID): A systematic review and meta-analysis. | Falla M et al. | β | 2021 | β |
| Genetic Vulnerability to Opioid Addiction. | Reed B et al. | β | 2021 | β |
| Ligand-specific pharmacogenetic effects of nonsynonymous mutations. | Morningstar-Kywi N et al. | β | 2021 | β |
| Multifocal Analysis of Acute Pain After Third Molar Removal. | Weckwerth GM et al. | β | 2021 | β |
| Overview of Genetic Analysis of Human Opioid Receptors. | Spampinato SM | β | 2021 | β |
| Personality traits and polymorphisms of genes coding neurotransmitter receptors or transporters: review of single gene and genome-wide association studies. | ZmorzyΕski S et al. | β | 2021 | β |
| Polymorphisms of the ΞΌ-opioid receptor gene influence cerebral pain processing in fibromyalgia. | Ellerbrock I et al. | β | 2021 | β |
| Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis. | Levran O et al. | β | 2021 | β |
| Predictive Factors of Opioid-Induced Nausea in Cancer Patients. | Ogawa Y et al. | β | 2021 | β |
| Reviewing pharmacogenetics to advance precision medicine for opioids. | Magarbeh L et al. | β | 2021 | β |
| The association between selected genetic variants and individual differences in experimental pain. | Lie MU et al. | β | 2021 | β |
| The Molecular Basis of Alcohol Use Disorder (AUD). Genetics, Epigenetics, and Nutrition in AUD: An Amazing Triangle. | Siomek-Gorecka A et al. | β | 2021 | β |
| The Persistent Challenge of Developing Addiction Pharmacotherapies. | Swinford-Jackson SE et al. | β | 2021 | β |
| Translational Research in Nicotine Addiction. | Fisher ML et al. | β | 2021 | β |
| Variation in the ΞΌ-opioid receptor gene (OPRM1) and experiences of felt security in response to a romantic partner's quarrelsome behavior. | Tchalova K et al. | β | 2021 | β |
| Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons. | Halikere A et al. | β | 2020 | β |
| A functional polymorphism in the ATP-Binding Cassette B1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients. | Benavides R et al. | β | 2020 | β |
| An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence. | Lin Y et al. | β | 2020 | β |
| Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. | Zhou H et al. | β | 2020 | β |
| A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane <i>ΞΌ-</i>Opioid Receptor through Heterodimerization. | Zhang T et al. | β | 2020 | β |
| COMT gene variants and Ξ²-endorphin levels contribute to ethnic differences in experimental pain sensitivity. | Xu F et al. | β | 2020 | β |
| Differential sensitivity of human neurons carrying ΞΌ opioid receptor (MOR) N40D variants in response to ethanol. | Scarnati MS et al. | β | 2020 | β |
| Effectiveness of Low-Dose Intravenous Fentanyl for Postoperative Headache Management After Neck Clipping of Ruptured Intracranial Aneurysms. | Terakado T et al. | β | 2020 | β |
| Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials. | Saad Z et al. | β | 2020 | β |
| Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach. | Emery MA et al. | β | 2020 | β |
| Genes and environment in attachment. | Picardi A et al. | β | 2020 | β |
| Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence. | Fang CP et al. | β | 2020 | β |
| Genome-Wide Association Study of Opioid Cessation. | Cox JW et al. | β | 2020 | β |
| Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment. | Tolami HF et al. | β | 2020 | β |
| Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference. | Collins D et al. | β | 2020 | β |
| Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. | Abijo T et al. | β | 2020 | β |
| Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. | Anton RF et al. | β | 2020 | β |
| Opioid and neuroHIV Comorbidity - Current and Future Perspectives. | Fitting S et al. | β | 2020 | β |
| Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. | Balyan R et al. | β | 2020 | β |
| Post-translational Modifications of Opioid Receptors. | Lemos Duarte M et al. | β | 2020 | β |
| Racial Disparities in Pediatric Anesthesia. | Baetzel AE et al. | β | 2020 | β |
| Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration. | Zhang Y et al. | β | 2020 | β |
| Sedative and Analgesic Pharmacokinetics During Pediatric ECMO. | Zimmerman KO et al. | β | 2020 | β |
| Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder. | Hartwell EE et al. | β | 2020 | β |
| The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience. | al'Absi M | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| Translational Molecular Approaches in Substance Abuse Research. | Fulton SL et al. | β | 2020 | β |
| Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. | Randesi M et al. | β | 2020 | β |
| Variation of the human mu-opioid receptor (OPRM1) gene predicts vulnerability to frustration. | Daniel AM et al. | β | 2020 | β |
| What's new in chronic pain pathophysiology. | Cohen I et al. | β | 2020 | β |
| A review of opioid addiction genetics. | Crist RC et al. | β | 2019 | β |
| Associations among the opioid receptor gene (<i>OPRM1</i>) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study. | Kim KM et al. | β | 2019 | β |
| Binge-Like Eating Is Not Influenced by the Murine Model of <i>OPRM1</i> A118G Polymorphism. | Sachdeo BLY et al. | β | 2019 | β |
| Coevolution of Residues Provides Evidence of a Functional Heterodimer of 5-HT<sub>2A</sub>R and 5-HT<sub>2C</sub>R Involving Both Intracellular and Extracellular Domains. | Fongang B et al. | β | 2019 | β |
| Current status of opioid addiction treatment and related preclinical research. | Kreek MJ et al. | β | 2019 | β |
| Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. | Hansson AC et al. | β | 2019 | β |
| Dynamics of heroin molecule inside the lipid membrane: a molecular dynamics study. | Singh S | β | 2019 | β |
| Effects of <i>OPRM1</i> and <i>ABCB1</i> gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer. | Zhao Z et al. | β | 2019 | β |
| Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis. | Yu Z et al. | β | 2019 | β |
| Escalated Oxycodone Self-Administration and Punishment: Differential Expression of Opioid Receptors and Immediate Early Genes in the Rat Dorsal Striatum and Prefrontal Cortex. | Blackwood CA et al. | β | 2019 | β |
| Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors. | Butelman ER et al. | β | 2019 | β |
| Increased risk of intracranial hemorrhage in preterm infants with OPRM1 gene A118G polymorphism. | Cheng XR et al. | β | 2019 | β |
| <i>OPRM1</i> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. | Taqi MM et al. | β | 2019 | β |
| Labour analgesia; Molecular pathway and the role of nanocarriers: a systematic review. | Kafshdooz L et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Opioids in cancer-related pain: current situation and outlook. | George B et al. | β | 2019 | β |
| Parkinson's disease management and impulse control disorders: current state and future perspectives. | Vitale C et al. | β | 2019 | β |
| Pharmacogenetics and levodopa induced motor complications. | Kalinderi K et al. | β | 2019 | β |
| Pharmacogenetics of alcohol addiction: current perspectives. | Zastrozhin MS et al. | β | 2019 | β |
| Potential biomarkers for persistent and neuropathic pain therapy. | Sisignano M et al. | β | 2019 | β |
| Risk Factors and Prevention Strategies for Postoperative Opioid Abuse. | Zhao S et al. | β | 2019 | β |
| Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry. | Popova D et al. | β | 2019 | β |
| Targeting opioid dysregulation in depression for the development of novel therapeutics. | Browne CA et al. | β | 2019 | β |
| The association between the OPRM1 A118G polymorphism and addiction in a Turkish population. | TΓΌrkan H et al. | β | 2019 | β |
| The Influence of Endogenous Opioids on the Relationship between Testosterone and Romantic Bonding. | Ponzi D et al. | β | 2019 | β |
| Transgenic increase in the Ξ²-endorphin concentration in cerebrospinal fluid alleviates morphine-primed relapse behavior through the ΞΌ opioid receptor in rats. | He Y et al. | β | 2019 | β |
| 4218T/C polymorphism associations with post-cesarean patient-controlled epidural fentanyl consumption and pain perception. | Xie W et al. | β | 2018 | β |
| Chronic Oxycodone Self-administration Altered Reward-related Genes in the Ventral and Dorsal Striatum of C57BL/6J Mice: An RNA-seq Analysis. | Zhang Y et al. | β | 2018 | β |
| Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach. | Sluiter RL et al. | β | 2018 | β |
| Development of an AmpliSeq<sup>TM</sup> Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain. | Kringel D et al. | β | 2018 | β |
| Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions. | Butelman ER et al. | β | 2018 | β |
| Dynamic lateral organization of opioid receptors (kappa, mu<sub>wt</sub> and mu<sub>N40D</sub> ) in the plasma membrane at the nanoscale level. | Rogacki MK et al. | β | 2018 | β |
| Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. | Ebrahimi G et al. | β | 2018 | β |
| Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan. | Li DJ et al. | β | 2018 | β |
| Fine-Tuning Limited Proteolysis: A Major Role for Regulated Site-Specific O-Glycosylation. | Goth CK et al. | β | 2018 | β |
| Gender-specific association of functional <i>prodynorphin</i> 68 bp repeats with cannabis exposure in an African American cohort. | Yuferov V et al. | β | 2018 | β |
| Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies. | Politi C et al. | β | 2018 | β |
| Heroin-induced suppression of saccharin intake in OPRM1 A118G mice. | Freet CS et al. | β | 2018 | β |
| Human pain genetics database: a resource dedicated to human pain genetics research. | Meloto CB et al. | β | 2018 | β |
| Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis. | Ahmed M et al. | β | 2018 | β |
| Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms. | Henderson-Redmond AN et al. | β | 2018 | β |
| Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. | Blum K et al. | β | 2018 | β |
| Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics. | Zhou Y et al. | β | 2018 | β |
| Molecular Genetics and New Medication Strategies for Opioid Addiction. | Hurd YL et al. | β | 2018 | β |
| Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. | Kosten TR et al. | β | 2018 | β |
| Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis. | Butelman ER et al. | β | 2018 | β |
| Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran. | Soleimani Asl S et al. | β | 2018 | β |
| Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice. | Collins D et al. | β | 2018 | β |
| OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients. | Muriel J et al. | β | 2018 | β |
| Parental overcontrol x OPRM1 genotype interaction predicts school-aged children's sympathetic nervous system activation in response to performance challenge. | Partington LC et al. | β | 2018 | β |
| Pharmacogenetics of Methadone Response. | Fonseca F et al. | β | 2018 | β |
| Pharmacogenetics of opioid analgesics in dogs. | Kongara K | β | 2018 | β |
| Pharmacogenetics of Opioid Use and Implications for Pain Management. | Nerenz RD et al. | β | 2018 | β |
| Pharmacogenomics of analgesics in anesthesia practice: A current update of literature. | Gray K et al. | β | 2018 | β |
| Predictive Model for the Sequence-Dependent Fluorogenic Response of Forced-Intercalation Peptide Nucleic Acid. | Peled I et al. | β | 2018 | β |
| Putative Independent Evolutionary Reversals from Genotypic to Temperature-Dependent Sex Determination are Associated with Accelerated Evolution of Sex-Determining Genes in Turtles. | Literman R et al. | β | 2018 | β |
| The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia. | Aslaksen PM et al. | β | 2018 | β |
| The Role of Circulating Ξ²-endorphin in Different Stress Models in Equines: A Review | Ferlazzo A et al. | β | 2018 | β |
| Touch-induced face conditioning is mediated by genetic variation in opioid but not oxytocin receptors. | Fu Y et al. | β | 2018 | β |
| Truncated ΞΌ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia. | Lu Z et al. | β | 2018 | β |
| A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use. | Otto JM et al. | β | 2017 | β |
| Association of Variants of Arginine Vasopressin and ArginineΒ Vasopressin Receptor 1A With Severe AcetaminophenΒ Liver Injury. | Randesi M et al. | β | 2017 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? | Butelman ER et al. | β | 2017 | β |
| Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome. | Wasilewski A et al. | β | 2017 | β |
| Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems. | Yeung EW et al. | β | 2017 | β |
| Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. | Gao X et al. | β | 2017 | β |
| Convergent Balancing Selection on the Mu-Opioid Receptor in Primates. | Sweeney CG et al. | β | 2017 | β |
| Effects of Single Nucleotide Polymorphisms on Surgical and Postsurgical Opioid Requirements: A Systematic Review and Meta-Analysis. | Choi SW et al. | β | 2017 | β |
| Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses. | Kringel D et al. | β | 2017 | β |
| Epigenetic correlates of neonatal contact in humans. | Moore SR et al. | β | 2017 | β |
| Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism. | Browne CA et al. | β | 2017 | β |
| Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. | Hirasawa-Fujita M et al. | β | 2017 | β |
| Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers. | Weerts EM et al. | β | 2017 | β |
| Key Pharmacogenomic Considerations for Sickle Cell Disease Patients. | Kolliopoulou A et al. | β | 2017 | β |
| Low back pain in older adults: risk factors, management options and future directions. | Wong AYL et al. | β | 2017 | β |
| Low ΞΌ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. | Hermann D et al. | β | 2017 | β |
| Neural response to alcohol taste cues in youth: effects of the OPRM1 gene. | Korucuoglu O et al. | β | 2017 | β |
| OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. | Hajj A et al. | β | 2017 | β |
| OPRM1 genotype interacts with serotonin system dysfunction to predict alcohol-heightened aggression in primates. | Driscoll CA et al. | β | 2017 | β |
| Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. | Schacht JP et al. | β | 2017 | β |
| Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models. | Rinker JA et al. | β | 2017 | β |
| Remifentanil consumption in septoplasty surgery under general anesthesia. Association with humane mu-opioid receptor gene variants. | Al-Mustafa MM et al. | β | 2017 | β |
| Reply. | Matic M et al. | β | 2017 | β |
| Similarities and Differences in Genetics. | Zhang Y et al. | β | 2017 | β |
| Spicy Food Preference and Risk for Alcohol Dependence in Korean. | Park JH et al. | β | 2017 | β |
| The Role of Chronic Psychosocial Stress in Explaining Racial Differences in Stress Reactivity and Pain Sensitivity. | Gordon JL et al. | β | 2017 | β |
| The ΞΌ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment. | Levran O et al. | β | 2017 | β |
| A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. | Bernardi RE et al. | β | 2016 | β |
| Alcohol addiction and the mu-opioid receptor. | Berrettini W | β | 2016 | β |
| An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. | Mnika K et al. | β | 2016 | β |
| Association between Gene Polymorphisms and Pain Sensitivity Assessed in a Multi-Modal Multi-Tissue Human Experimental Model - An Explorative Study. | Nielsen LM et al. | β | 2016 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| Association study of DRD2 A2/A1, DRD3 Ser9Gly, DΞ²H -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence. | Ragia G et al. | β | 2016 | β |
| Effects of fentanyl administration on locomotor response in horses with the G57C ΞΌ-opioid receptor polymorphism. | Wetmore LA et al. | β | 2016 | β |
| Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. | Bujarski S et al. | β | 2016 | β |
| Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438Β A/G on Speed-Dating Success. | Wu K et al. | β | 2016 | β |
| Genetic mechanisms of parenting. | Mileva-Seitz VR et al. | β | 2016 | β |
| Genetic variants associated with thermal pain sensitivity in a paediatric population. | Matic M et al. | β | 2016 | β |
| Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking. | Phillips TJ et al. | β | 2016 | β |
| Indoor tanning bed use and risk of food addiction based on the modified Yale Food Addiction Scale. | Li WQ et al. | β | 2016 | β |
| Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration. | Lechner WV et al. | β | 2016 | β |
| Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism. | Henderson-Redmond AN et al. | β | 2016 | β |
| Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential. | Soyka M | β | 2016 | β |
| Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeqβ’ library and ion torrent personal genome machine. | Kringel D et al. | β | 2016 | β |
| Novel Probes Establish Mas-Related G Protein-Coupled Receptor X1 Variants as Receptors with Loss or Gain of Function. | Heller D et al. | β | 2016 | β |
| Opioid Antagonists and the A118G Polymorphism in the ΞΌ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. | Ziauddeen H et al. | β | 2016 | β |
| Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction. | Berrettini W | β | 2016 | β |
| Opioids and social bonding: naltrexone reduces feelings of social connection. | Inagaki TK et al. | β | 2016 | β |
| Pain tolerance predicts human social network size. | Johnson KV et al. | β | 2016 | β |
| Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. | Valenza M et al. | β | 2016 | β |
| Studying longitudinal trajectories in animal models of psychiatric illness and their translation to the human condition. | Driscoll CA et al. | β | 2016 | β |
| T394A Mutation at the ΞΌ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice. | Wang XF et al. | β | 2016 | β |
| The Influence of Genotype Polymorphism on Morphine Analgesic Effect for Postoperative Pain in Children. | Lee MG et al. | β | 2016 | β |
| The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research. | Heilig M et al. | β | 2016 | β |
| Translational Research on Nicotine Dependence. | Falcone M et al. | β | 2016 | β |
| Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. | Soyka M et al. | β | 2016 | β |
| What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. | Le Foll B | β | 2016 | β |
| What the alcohol doctor ordered from the neuroscientist: Theragnostic biomarkers for personalized treatments. | Heilig M et al. | β | 2016 | β |
| Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. | Patriquin MA et al. | β | 2015 | β |
| Advances in Medications and Tailoring Treatment for Alcohol Use Disorder. | Seneviratne C et al. | β | 2015 | β |
| Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms. | Mascarenhas R et al. | β | 2015 | β |
| A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. | Bilbao A et al. | β | 2015 | β |
| Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population. | FrancΓ¨s F et al. | β | 2015 | β |
| Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. | Chidambaran V et al. | β | 2015 | β |
| Bioinformatics and evolution of vertebrate nociceptin and opioid receptors. | Stevens CW | β | 2015 | β |
| Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human ΞΌ-opioid receptor (OPRM1). | Knapman A et al. | β | 2015 | β |
| CGRP 4218T/C polymorphism correlated with postoperative analgesic effect of fentanyl. | Yi Y et al. | β | 2015 | β |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | β | 2015 | β |
| Cocaine-induced suppression of saccharin intake and morphine modulation of CaΒ²βΊ channel currents in sensory neurons of OPRM1 A118G mice. | Freet CS et al. | β | 2015 | β |
| Co-development of early adolescent alcohol use and depressive feelings: The role of the mu-opioid receptor A118G polymorphism. | Kleinjan M et al. | β | 2015 | β |
| Common single nucleotide variants underlying drug addiction: more than a decade of research. | BΓΌhler KM et al. | β | 2015 | β |
| Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G. | Lovallo WR et al. | β | 2015 | β |
| Decreased [3H]naloxone Binding in the Dentate Gyrus of Cloninger Type 1 Anxiety-Prone Alcoholics: A Postmortem Whole-Hemisphere Autoradiography Study. | Laukkanen V et al. | β | 2015 | β |
| Detection of mu opioid receptor (MOPR) and its glycosylation in rat and mouse brains by western blot with anti-ΞΌC, an affinity-purified polyclonal anti-MOPR antibody. | Huang P et al. | β | 2015 | β |
| Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. | PeciΓ±a M et al. | β | 2015 | β |
| Effects of Β΅-Opioid Receptor Gene Polymorphism on Postoperative Nausea and Vomiting in Patients Undergoing General Anesthesia with Remifentanil: Double Blinded Randomized Trial. | Lee SH et al. | β | 2015 | β |
| Examining gene-environment interactions in comorbid depressive and disruptive behavior disorders using a Bayesian approach. | Adrian M et al. | β | 2015 | β |
| Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. | Woodcock EA et al. | β | 2015 | β |
| Gene-gene interaction of ΞΌ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect. | Misailidis G et al. | β | 2015 | β |
| Genotyping test with clinical factors: better management of acute postoperative pain? | Hajj A et al. | β | 2015 | β |
| Human population genetic structure detected by pain-related mu opioid receptor gene polymorphisms. | LΓ³pez Soto EJ et al. | β | 2015 | β |
| Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects. | Bach P et al. | β | 2015 | β |
| Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia. | Sastre JA et al. | β | 2015 | β |
| Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. | Samuel M et al. | β | 2015 | β |
| Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function. | Mague SD et al. | β | 2015 | β |
| Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice. | Zhang Y et al. | β | 2015 | β |
| Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section. | Xu GH et al. | β | 2015 | β |
| OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients. | Foulds JA et al. | β | 2015 | β |
| Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism. | Robinson JE et al. | β | 2015 | β |
| Regional brain [(11)C]carfentanil binding following tobacco smoking. | Domino EF et al. | β | 2015 | β |
| Sensitive determination of methadone in human serum and urine by dispersive liquid-liquid microextraction based on the solidification of a floating organic droplet followed by HPLC-UV. | Taheri S et al. | β | 2015 | β |
| Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides. | Vardy E et al. | β | 2015 | β |
| Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. | Roche DJ et al. | β | 2015 | β |
| The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. | Bauer IE et al. | β | 2015 | β |
| A118G polymorphism in the ΞΌ-opioid receptor gene and levels of Ξ²-endorphin are associated with provoked vestibulodynia and pressure pain sensitivity. | Heddini U et al. | β | 2014 | β |
| A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the ΞΌ opioid receptor gene OPRM1 via hnRNPH interactions. | Xu J et al. | β | 2014 | β |
| Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. | Zhou Y et al. | β | 2014 | β |
| A psycho-genetic study of hedonic responsiveness in relation to "food addiction". | Davis C et al. | β | 2014 | β |
| Assessment of opioid receptor ΞΌ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. | Solak Γ et al. | β | 2014 | β |
| Association between single nucleotide polymorphisms in the OPRM1 gene and intraoperative remifentanil consumption in northern Chinese women. | Liu J et al. | β | 2014 | β |
| Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. | Nelson EC et al. | β | 2014 | β |
| Association of ΞΌ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting. | Sugino S et al. | β | 2014 | β |
| Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPΞ³S binding in mice with Oprm1 A112G. | Wang YJ et al. | β | 2014 | β |
| Buprenorphine signalling is compromised at the N40D polymorphism of the human ΞΌ opioid receptor in vitro. | Knapman A et al. | β | 2014 | β |
| Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. | Wachman EM et al. | β | 2014 | β |
| Exploration of known stereotypic behaviour-related candidate genes in equine crib-biting. | Hemmann K et al. | β | 2014 | β |
| FCER2 (CD23) asthma-related single nucleotide polymorphisms yields increased IgE binding and Egr-1 expression in human B cells. | Chan MA et al. | β | 2014 | β |
| Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). | Blum K et al. | β | 2014 | β |
| Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism. | Enoch MA | β | 2014 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence. | Mistry CJ et al. | β | 2014 | β |
| Higher frequency of C.3435 of the ABCB1 gene in patients with tramadol dependence disorder. | Enabah D et al. | β | 2014 | β |
| How much oxycodone is needed for adequate analgesia after breast cancer surgery: effect of the OPRM1 118A>G polymorphism. | Cajanus K et al. | β | 2014 | β |
| Human germline and pan-cancer variomes and their distinct functional profiles. | Pan Y et al. | β | 2014 | β |
| Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients. | Tashiro M et al. | β | 2014 | β |
| Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption. | Bastami S et al. | β | 2014 | β |
| Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. | Ray LA et al. | β | 2014 | β |
| Initial responses to the first dose of nicotine in novel smokers: the role of exposure to environmental smoking and genetic predisposition. | Schuck K et al. | β | 2014 | β |
| Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. | Hauser KF et al. | β | 2014 | β |
| Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. | Ray LA et al. | β | 2014 | β |
| Lack of association between DRD2 and OPRM1 genotypes and adiposity. | Hardman CA et al. | β | 2014 | β |
| Letting the gene out of the bottle: OPRM1 interactions. | Belfer I et al. | β | 2014 | β |
| Mu opioid receptor gene: new point mutations in opioid addicts. | Dinarvand A et al. | β | 2014 | β |
| Nalmefene for the treatment of alcohol dependence: a current update. | Soyka M | β | 2014 | β |
| Neurogenetics of aggressive behavior: studies in primates. | Barr CS et al. | β | 2014 | β |
| Pharmacogenetics of addiction therapy. | Nielsen DA et al. | β | 2014 | β |
| Pharmacogenetics of OPRM1. | Crist RC et al. | β | 2014 | β |
| Pharmacogenomics of methadone maintenance treatment. | Somogyi AA et al. | β | 2014 | β |
| Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data. | Kaur H et al. | β | 2014 | β |
| Polymorphism in the ΞΌ-opioid receptor gene OPRM1 A118G -An example of the enigma of genetic variability behind chronic pain syndromes. | Klepstad P | β | 2014 | β |
| Targeting opioid receptors with pharmacological chaperones. | PetΓ€jΓ€-Repo UE et al. | β | 2014 | β |
| The association of genetic polymorphisms in the ΞΊ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance. | Wang SC et al. | β | 2014 | β |
| A machine-learned knowledge discovery method for associating complex phenotypes with complex genotypes. Application to pain. | LΓΆtsch J et al. | β | 2013 | β |
| Analgesia and central side-effects: two separate dimensions of morphine response. | Droney JM et al. | β | 2013 | β |
| Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder. | Cooper AJ et al. | β | 2013 | β |
| Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. | Carpenter CL et al. | β | 2013 | β |
| Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. | Levran O et al. | β | 2013 | β |
| Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. | Wachman EM et al. | β | 2013 | β |
| Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. | Ding S et al. | β | 2013 | β |
| Combined analysis of circulating Ξ²-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. | Rhodin A et al. | β | 2013 | β |
| Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? | Mura E et al. | β | 2013 | β |
| Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G ΞΌ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations. | Ginosar Y et al. | β | 2013 | β |
| ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. | Daws SE et al. | β | 2013 | β |
| Epigenetics: a promising paradigm for better understanding and managing pain. | Seo S et al. | β | 2013 | β |
| Fronto-striatal functional connectivity during response inhibition in alcohol dependence. | Courtney KE et al. | β | 2013 | β |
| Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. | Gong XD et al. | β | 2013 | β |
| Genes and epigenetic processes as prospective pain targets. | Crow M et al. | β | 2013 | β |
| Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations. | Lawhorn C et al. | β | 2013 | β |
| Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. | De Gregori M et al. | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Improving clinical outcomes for naltrexone as a management of problem alcohol use. | Hulse GK | β | 2013 | β |
| Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. | Weerts EM et al. | β | 2013 | β |
| Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. | Schacht JP et al. | β | 2013 | β |
| Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients. | Marini V et al. | β | 2013 | β |
| Lack of association of OPRM1 genotype and smoking cessation. | MunafΓ² MR et al. | β | 2013 | β |
| Large-scale polymorphism discovery in macaque G-protein coupled receptors. | Goswami DB et al. | β | 2013 | β |
| Low frequency genetic variants in the ΞΌ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. | Clarke TK et al. | β | 2013 | β |
| Modeling the influence of the A118G polymorphism in the OPRM1 gene and of noxious stimulation on the synergistic relation between propofol and remifentanil: sedation and analgesia in endoscopic procedures. | Borrat X et al. | β | 2013 | β |
| Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone. | Ducat E et al. | β | 2013 | β |
| Mu opioids and their receptors: evolution of a concept. | Pasternak GW et al. | β | 2013 | β |
| Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome. | McLemore GL et al. | β | 2013 | β |
| Opioid pharmacogenetics of alcohol addiction. | Berrettini W | β | 2013 | β |
| Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. | Manini AF et al. | β | 2013 | β |
| Opioid receptors control viral replication in the airways. | Salimi V et al. | β | 2013 | β |
| Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs. | Xu Y et al. | β | 2013 | β |
| OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. | Chen YT et al. | β | 2013 | β |
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. | Haerian BS et al. | β | 2013 | β |
| Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment. | Jacob C | β | 2013 | β |
| Pharmacogenetics of chronic pain and its treatment. | SvΔtlΓk S et al. | β | 2013 | β |
| Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg. | Hajj A et al. | β | 2013 | β |
| Polymorphism of ΞΌ-Opioid Receptor Gene (OPRM1:c.118A>G) Might Not Protect against or Enhance Morphine-Induced Nausea or Vomiting. | Chen LK et al. | β | 2013 | β |
| Recent developments in the study of opioid receptors. | Cox BM | β | 2013 | β |
| Regulation of ΞΌ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. | Williams JT et al. | β | 2013 | β |
| State of art of managing pain in patients with cancer. | Dalal S et al. | β | 2013 | β |
| Subjective response to alcohol among alcohol-dependent individuals: effects of the ΞΌ-opioid receptor (OPRM1) gene and alcoholism severity. | Ray LA et al. | β | 2013 | β |
| Targeted opioid receptor antagonists in the treatment of alcohol use disorders. | Niciu MJ et al. | β | 2013 | β |
| The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. | Henker RA et al. | β | 2013 | β |
| The correlation between post-operative fentanyl requirements and <i>ΞΌ</i>-opioid receptor gene A118G polymorphism in patients undergoing radical gastrectomy. | Zhang F et al. | β | 2013 | β |
| The ΞΌ-opioid receptor and treatment response to naltrexone. | Thorsell A | β | 2013 | β |
| ΞΌ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. | Rouvinen-LagerstrΓΆm N et al. | β | 2013 | β |
| Β΅-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain. | Walter C et al. | β | 2013 | β |
| A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels. | Lopez Soto EJ et al. | β | 2012 | β |
| A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. | Crystal HA et al. | β | 2012 | β |
| A common single nucleotide polymorphism A118G of theΒ ΞΌ opioid receptor alters its N-glycosylation and protein stability. | Huang P et al. | β | 2012 | β |
| A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter? | Rahim-Williams B et al. | β | 2012 | β |
| Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. | Proudnikov D et al. | β | 2012 | β |
| Association of Β΅-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. | Chamorro AJ et al. | β | 2012 | β |
| A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. | Verhagen M et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Convergence of genome-wide association and candidate gene studies for alcoholism. | Olfson E et al. | β | 2012 | β |
| Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. | Ashenhurst JR et al. | β | 2012 | β |
| Endophenotypes as a measure of suicidality. | Chistiakov DA et al. | β | 2012 | β |
| Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity. | Hastie BA et al. | β | 2012 | β |
| Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians. | Chen D et al. | β | 2012 | β |
| Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. | Nielsen DA et al. | β | 2012 | β |
| Genetic-epigenetic interaction modulates ΞΌ-opioid receptor regulation. | Oertel BG et al. | β | 2012 | β |
| Genetic factors modulating the response to stimulant drugs in humans. | Hart AB et al. | β | 2012 | β |
| Genetic Influences on Physiological and Subjective Responses to an Aerobic Exercise Session among Sedentary Adults. | Karoly HC et al. | β | 2012 | β |
| Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. | Wang SC et al. | β | 2012 | β |
| Genetics and genomics: unraveling new opportunities for addiction treatment and education. | Snow D et al. | β | 2012 | β |
| Genome-wide genetic associations with IFNΞ³ response to smallpox vaccine. | Kennedy RB et al. | β | 2012 | β |
| Geographic differences in perioperative opioid administration in children. | Rabbitts JA et al. | β | 2012 | β |
| Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy. | Liu YC et al. | β | 2012 | β |
| Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. | Setiawan E et al. | β | 2012 | β |
| Influence of the OPRM1 gene polymorphism upon children's degree of withdrawal and brain activation in response to facial expressions. | Bertoletti E et al. | β | 2012 | β |
| Modeling borderline personality disorder based on the neurobehavioral foundation of major personality traits. | Depue RA et al. | β | 2012 | β |
| Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent. | Al-Eitan LN et al. | β | 2012 | β |
| Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. | Kreek MJ et al. | β | 2012 | β |
| OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV. | Nugent NR et al. | β | 2012 | β |
| Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction. | Olsen MB et al. | β | 2012 | β |
| Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors. | Somvanshi RK et al. | β | 2012 | β |
| Pharmacogenetics of alcoholism: a clinical neuroscience perspective. | Ray LA et al. | β | 2012 | β |
| Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. | Ray LA et al. | β | 2012 | β |
| Pharmacogenomic considerations in opioid analgesia. | Vuilleumier PH et al. | β | 2012 | β |
| Pharmacogenomics of opioids and perioperative pain management. | Sadhasivam S et al. | β | 2012 | β |
| Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms. | Koller G et al. | β | 2012 | β |
| Rational development of addiction pharmacotherapies: successes, failures, and prospects. | Pierce RC et al. | β | 2012 | β |
| Reduced expression of the ΞΌ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G. | Wang YJ et al. | β | 2012 | β |
| Testing multiple levels of influence in the intergenerational transmission of alcohol disorders from a developmental perspective: the example of alcohol use promoting peers and ΞΌ-opioid receptor M1 variation. | Chassin L et al. | β | 2012 | β |
| The A118G single-nucleotide polymorphism of human ΞΌ-opioid receptor gene and use of labor analgesia. | Pettersson FD et al. | β | 2012 | β |
| The differential profiles of withdrawal symptoms induced by morphine and beta-endorphin administered intracerebroventricularly in mice. | Park SH et al. | β | 2012 | β |
| The genetics of addiction-a translational perspective. | Agrawal A et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| The human ΞΌ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients. | Menon S et al. | β | 2012 | β |
| The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. | Ray LA et al. | β | 2012 | β |
| Translational advances in pain and anesthesia for cancer patients. | Maani CV et al. | β | 2012 | β |
| Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. | Bujarski S et al. | β | 2012 | β |
| Variation in the ΞΌ-opioid receptor gene (OPRM1) moderates the influence of early maternal care on fearful attachment. | Troisi A et al. | β | 2012 | β |
| Addictive genes and the relationship to obesity and inflammation. | Heber D et al. | β | 2011 | β |
| A genetic determinant of the striatal dopamine response to alcohol in men. | Ramchandani VA et al. | β | 2011 | β |
| An overview of the genetic susceptibility to alcoholism. | Buscemi L et al. | β | 2011 | β |
| Asthma-related SNP in FCER2 is associated with increased expression of IL-4R on human B cells. | Chan MA et al. | β | 2011 | β |
| Child ΞΌ-opioid receptor gene variant influences parent-child relations. | Copeland WE et al. | β | 2011 | β |
| Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. | Kolesnikov Y et al. | β | 2011 | β |
| CYP2B6 and OPRM1 gene variations predict methadone-related deaths. | Bunten H et al. | β | 2011 | β |
| Detection of single nucleotide polymorphism using tension-dependent stochastic behavior of a single-molecule template. | Koirala D et al. | β | 2011 | β |
| Effect of ethnicity on the hypnotic and cardiovascular characteristics of propofol induction. | Natarajan A et al. | β | 2011 | β |
| Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids. | Diatchenko L et al. | β | 2011 | β |
| Evolving knowledge of opioid genetics in cancer pain. | Droney J et al. | β | 2011 | β |
| Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. | Kreek MJ | β | 2011 | β |
| Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans. | Lee MR et al. | β | 2011 | β |
| Functions of arginine vasopressin and its receptors: importance of human molecular genetics studies in bidirectional translational research. | Kreek MJ et al. | β | 2011 | β |
| Genetics in pain management. | Chien CC | β | 2011 | β |
| Genetics of alcohol dependence. | Kimura M et al. | β | 2011 | β |
| Genetics of tardive dyskinesia. | Lee HJ et al. | β | 2011 | β |
| Genetic variability of pain perception and treatment--clinical pharmacological implications. | LΓΆtsch J | β | 2011 | β |
| Genetic vulnerability and susceptibility to substance dependence. | Bierut LJ | β | 2011 | β |
| Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. | Ray R et al. | β | 2011 | β |
| Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients. | De Capraris A et al. | β | 2011 | β |
| Molecular mechanisms of opioid receptor-dependent signaling and behavior. | Al-Hasani R et al. | β | 2011 | β |
| Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulatta. | Higham JP et al. | β | 2011 | β |
| Neurogenetic and experiential processes underlying major personality traits: implications for modelling personality disorders. | Depue RA et al. | β | 2011 | β |
| No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. | Nikolov MA et al. | β | 2011 | β |
| Pharmacogenetic approaches to the treatment of alcohol addiction. | Heilig M et al. | β | 2011 | β |
| Pharmacogenetics of alcohol, nicotine and drug addiction treatments. | Sturgess JE et al. | β | 2011 | β |
| Pharmacogenomics of the human Β΅-opioid receptor. | Kasai S et al. | β | 2011 | β |
| Pharmacological consequence of the A118G ΞΌ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of CaΒ²βΊ channels in humanized mouse sensory neurons. | Mahmoud S et al. | β | 2011 | β |
| Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population. | Lloret Linares C et al. | β | 2011 | β |
| Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference. | Laaksonen E et al. | β | 2011 | β |
| Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients. | Troisi A et al. | β | 2011 | β |
| Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. | Ray LA | β | 2011 | β |
| Suppression of acute morphine withdrawal syndrome by adenovirus-mediated Ξ²-endorphin in rats. | He Y et al. | β | 2011 | β |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. | Soyka M et al. | β | 2011 | β |
| Alcohol response and consumption in adolescent rhesus macaques: life history and genetic influences. | Schwandt ML et al. | β | 2010 | β |
| A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. | Vallender EJ et al. | β | 2010 | β |
| Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. | Zhang W et al. | β | 2010 | β |
| Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. | Garriock HA et al. | β | 2010 | β |
| Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. | Proudnikov D et al. | β | 2010 | β |
| Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain. | Cheng KI et al. | β | 2010 | β |
| Biological pathways and genetic variables involved in pain. | Shi Q et al. | β | 2010 | β |
| Breaking barriers in the genomics and pharmacogenetics of drug addiction. | Ho MK et al. | β | 2010 | β |
| ChIP-chip analysis of neurexins and other candidate genes for addiction and neuropsychiatric disorders. | Pedrosa E et al. | β | 2010 | β |
| Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. | Zhou Y et al. | β | 2010 | β |
| Evaluation of the influence of the codon 16 polymorphism of the Beta-2 adrenergic receptor gene on the incidence of arterial hypotension and ephedrine use in pregnant patients submitted to subarachnoid anesthesia. | MagalhΓ£es E et al. | β | 2010 | β |
| Genes and alcohol. | Osby U et al. | β | 2010 | β |
| Genetic influences on the dynamics of pain and affect in fibromyalgia. | Finan PH et al. | β | 2010 | β |
| Genetics of drug dependence. | Gelernter J et al. | β | 2010 | β |
| Genetic variation and brain gene expression in rodent models of alcoholism implications for medication development. | BjΓΆrk K et al. | β | 2010 | β |
| Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. | Comer SD et al. | β | 2010 | β |
| Identification of single nucleotide polymorphisms within exon 1 of the canine mu-opioid receptor gene. | Hawley AT et al. | β | 2010 | β |
| Individualised treatment in alcohol-dependent patients. | Mann K et al. | β | 2010 | β |
| Initial evidence of an association between OPRM1 and adolescent alcohol misuse. | Miranda R et al. | β | 2010 | β |
| Introduction to the College on Problems of Drug Dependence special issue: contemporary advances in opioid neuropharmacology. | Walsh SL et al. | β | 2010 | β |
| Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding. | Bailey A et al. | β | 2010 | β |
| Nalmefene for treatment of alcohol dependence. | Soyka M et al. | β | 2010 | β |
| Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. | Niikura K et al. | β | 2010 | β |
| Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. | Wong CA et al. | β | 2010 | β |
| OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. | Bunten H et al. | β | 2010 | β |
| OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. | Mague SD et al. | β | 2010 | β |
| Overview and historical perspective of four papers presented on research related to the endogenous opioid system. | Kreek MJ | β | 2010 | β |
| Perioperative analgesic treatment in Latino and non-Latino pediatric patients. | Jimenez N et al. | β | 2010 | β |
| Pharmacogenetic influences in obstetric anaesthesia. | Landau R | β | 2010 | β |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | β | 2010 | β |
| Pharmacogenetics of alcohol and alcohol dependence treatment. | Kranzler HR et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Pharmacotherapy in the treatment of addiction: methadone. | Kreek MJ et al. | β | 2010 | β |
| Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. | Ray LA et al. | β | 2010 | β |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | β | 2010 | β |
| Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. | Deb I et al. | β | 2010 | β |
| Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. | Ray LA et al. | β | 2010 | β |
| Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus. | Barr CS et al. | β | 2010 | β |
| The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. | Vossen H et al. | β | 2010 | β |
| The genetics of pain: implications for evaluation and treatment of spinal disease. | Kim DH et al. | β | 2010 | β |
| The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. | Stanley B et al. | β | 2010 | β |
| The role of N53Q mutation on the rat mu-opioid receptor function. | Rostami A et al. | β | 2010 | β |
| Tolerance and withdrawal from prolonged opioid use in critically ill children. | Anand KJ et al. | β | 2010 | β |
| Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. | Heilig M et al. | β | 2010 | β |
| Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. | Marteau TM et al. | β | 2010 | β |
| Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. | Ren ZY et al. | β | 2009 | β |
| A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. | Oertel BG et al. | β | 2009 | β |
| A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients. | Kim SG et al. | β | 2009 | β |
| A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. | Ray LA et al. | β | 2009 | β |
| Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. | Fukuda K et al. | β | 2009 | β |
| Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception. | Matsunaga M et al. | β | 2009 | β |
| Bidirectional translational research: Progress in understanding addictive diseases. | Kreek MJ et al. | β | 2009 | β |
| Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. | LΓΆtsch J et al. | β | 2009 | β |
| Current evidence for a modulation of low back pain by human genetic variants. | Tegeder I et al. | β | 2009 | β |
| Development of pharmacotherapies for drug addiction: a Rosetta stone approach. | Koob GF et al. | β | 2009 | β |
| Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. | Tan EC et al. | β | 2009 | β |
| Expansion of the human mu-opioid receptor gene architecture: novel functional variants. | Shabalina SA et al. | β | 2009 | β |
| From taste hedonics to motivational drive: central ΞΌ-opioid receptors and binge-eating behaviour. | Nathan PJ et al. | β | 2009 | β |
| Functional characterization of human variants of the mu-opioid receptor gene. | Ravindranathan A et al. | β | 2009 | β |
| Genetic, environmental, and epigenetic factors in the development of personality disturbance. | Depue RA | β | 2009 | β |
| High post surgical opioid requirements in Crohn's disease are not due to a general change in pain sensitivity. | Huehne K et al. | β | 2009 | β |
| Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. | Coller JK et al. | β | 2009 | β |
| Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. | Walter C et al. | β | 2009 | β |
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. | Mague SD et al. | β | 2009 | β |
| Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study. | Ginosar Y et al. | β | 2009 | β |
| Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. | Hardin J et al. | β | 2009 | β |
| Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of micro-opioid receptor gene in Japanese population. | Ono T et al. | β | 2009 | β |
| Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. | Boettiger CA et al. | β | 2009 | β |
| Opiate and cocaine addiction: from bench to clinic and back to the bench. | Kreek MJ et al. | β | 2009 | β |
| OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. | Oroszi G et al. | β | 2009 | β |
| OPRM1 gene is associated with BMI in Uyghur population. | Xu L et al. | β | 2009 | β |
| Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms. | Bruehl S et al. | β | 2009 | β |
| Pharmacogenomic variability and anaesthesia. | Searle R et al. | β | 2009 | β |
| Pharmacology of morphine in obese patients: clinical implications. | Lloret Linares C et al. | β | 2009 | β |
| Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. | Wu WD et al. | β | 2009 | β |
| Positive transcriptional regulation of the human micro opioid receptor gene by poly(ADP-ribose) polymerase-1 and increase of its DNA binding affinity based on polymorphism of G-172 -> T. | Ono T et al. | β | 2009 | β |
| Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. | Ooteman W et al. | β | 2009 | β |
| Recent advances in the use of opioids for cancer pain. | Droney J et al. | β | 2009 | β |
| Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. | Wiers RW et al. | β | 2009 | β |
| Role of the HPA axis and the A118G polymorphism of the mu-opioid receptor in stress-induced drinking behavior. | Pratt WM et al. | β | 2009 | β |
| Stress, alcohol and drug interaction: an update of human research. | Uhart M et al. | β | 2009 | β |
| Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. | Garbutt JC et al. | β | 2009 | β |
| The evolution of vertebrate opioid receptors. | Stevens CW | β | 2009 | β |
| The G allele of SNP E1/A118G at the mu-opioid receptor gene locus shows genomic evidence of recent positive selection. | Pang GS et al. | β | 2009 | β |
| The genetics of alcoholism. | Stacey D et al. | β | 2009 | β |
| The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans. | Du Y et al. | β | 2009 | β |
| The potential of pharmacogenomics to treat drug addiction. | Haile CN et al. | β | 2009 | β |
| Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences. | Ferrer-Dufol A et al. | β | 2009 | β |
| A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. | Sia AT et al. | β | 2008 | β |
| Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance. | Prosser JM et al. | β | 2008 | β |
| A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. | Hishimoto A et al. | β | 2008 | β |
| Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. | Hayashida M et al. | β | 2008 | β |
| An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. | Anton RF et al. | β | 2008 | β |
| Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*. | Huang CJ et al. | β | 2008 | β |
| Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS). | Ruchat SM et al. | β | 2008 | β |
| Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. | Ehlers CL et al. | β | 2008 | β |
| Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. | Crettol S et al. | β | 2008 | β |
| Beta-endorphin and drug-induced reward and reinforcement. | Roth-Deri I et al. | β | 2008 | β |
| Candidate gene polymorphisms predicting individual sensitivity to opioids. | Kasai S et al. | β | 2008 | β |
| Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. | Filbey FM et al. | β | 2008 | β |
| Differential opioid action on sensory and affective cerebral pain processing. | Oertel BG et al. | β | 2008 | β |
| Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | Arias AJ et al. | β | 2008 | β |
| Genetic approaches to addiction: genes and alcohol. | Ducci F et al. | β | 2008 | β |
| Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. | Anton RF | β | 2008 | β |
| Genetic contributions to pain: a review of findings in humans. | Fillingim RB et al. | β | 2008 | β |
| Genetic mutations that prevent pain: implications for future pain medication. | Oertel B et al. | β | 2008 | β |
| [Genetic polymorphisms and opioid therapies]. | Landau R | β | 2008 | β |
| Genetics and pain. | Persson E et al. | β | 2008 | β |
| Genetic susceptibility to heroin addiction: a candidate gene association study. | Levran O et al. | β | 2008 | β |
| Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. | Landau R et al. | β | 2008 | β |
| Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. | Nielsen DA et al. | β | 2008 | β |
| Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque. | Vallender EJ et al. | β | 2008 | β |
| Individual differences in opioid efficacy for chronic noncancer pain. | Riley JL et al. | β | 2008 | β |
| Interindividual variability of methadone response: impact of genetic polymorphism. | Li Y et al. | β | 2008 | β |
| Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates. | Butelman ER et al. | β | 2008 | β |
| Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. | Kakko J et al. | β | 2008 | β |
| Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not. | Abrahao KP et al. | β | 2008 | β |
| Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations. | Luo X et al. | β | 2008 | β |
| Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. | O'Malley SS et al. | β | 2008 | β |
| Naltrexone in the treatment of alcohol dependence. | Unterwald EM | β | 2008 | β |
| Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. | Dumas EO et al. | β | 2008 | β |
| Pharmacogenetics and obstetric anesthesia. | Landau R | β | 2008 | β |
| Pharmacogenetic treatments for drug addiction: alcohol and opiates. | Haile CN et al. | β | 2008 | β |
| Pharmacogenomics and perioperative medicine--implications for modern clinical practice. | Kim JH et al. | β | 2008 | β |
| Pharmacological analysis of human D1 AND D2 dopamine receptor missense variants. | Al-Fulaij MA et al. | β | 2008 | β |
| Preserved DNA from past clinical trials yields new information about a subtype of alcoholism. | O'Brien CP | β | 2008 | β |
| Pruritus in primary biliary cirrhosis: pathogenesis and therapy. | Bergasa NV | β | 2008 | β |
| Review. Evidence-based treatments of addiction. | O'Brien CP | β | 2008 | β |
| Rhesus monkey tryptophan hydroxylase-2 coding region haplotypes affect mRNA stability. | Chen GL et al. | β | 2008 | β |
| Role of a functional human gene polymorphism in stress responsivity and addictions. | Kreek MJ | β | 2008 | β |
| Role of pharmacogenetics in variable response to drugs: focus on opioids. | Kadiev E et al. | β | 2008 | β |
| The genetics of alcohol and other drug dependence. | Dick DM et al. | β | 2008 | β |
| The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity. | Bruehl S et al. | β | 2008 | β |
| The neurobiology and genetics of impulse control disorders: relationships to drug addictions. | Brewer JA et al. | β | 2008 | β |
| The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. | Zhang H et al. | β | 2008 | β |
| The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy. | Reynolds KK et al. | β | 2008 | β |
| Tobacco addiction. | Hatsukami DK et al. | β | 2008 | β |
| Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. | Johnson BA | β | 2008 | β |
| Variable response to opioid treatment: any genetic predictors within sight? | Skorpen F et al. | β | 2008 | β |
| Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. | Barr CS et al. | β | 2008 | β |
| A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. | Kapur S et al. | β | 2007 | β |
| A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. | van den Wildenberg E et al. | β | 2007 | β |
| A novel SNP detection technique utilizing a multiple primer extension (MPEX) on a phospholipid polymer-coated surface. | Imai K et al. | β | 2007 | β |
| Association of the mu-opioid receptor gene with smoking cessation. | MunafΓ² MR et al. | β | 2007 | β |
| Chronic facial pain in the female patient: treatment updates. | Stavropoulos F et al. | β | 2007 | β |
| Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression? | Crettol S et al. | β | 2007 | β |
| Current evidence for a modulation of nociception by human genetic polymorphisms. | LΓΆtsch J et al. | β | 2007 | β |
| Development of the Handy Bio-Strand and its application to genotyping of OPRM1 (A118G). | Ginya H et al. | β | 2007 | β |
| Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. | Zhang D et al. | β | 2007 | β |
| Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. | Glatt SJ et al. | β | 2007 | β |
| Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. | Reyes-Gibby CC et al. | β | 2007 | β |
| Genetic polymorphisms and idiopathic generalized epilepsies. | Lucarini N et al. | β | 2007 | β |
| Genomic variations and transcriptional regulation of the human mu-opioid receptor gene. | Bayerer B et al. | β | 2007 | β |
| Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. | Gerra G et al. | β | 2007 | β |
| Imagen: implications for addiction science and science policy. | Heilig M | β | 2007 | β |
| Is there genetic polymorphism evidence for individual human sensitivity to opiates? | Nagashima M et al. | β | 2007 | β |
| Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism. | Margas W et al. | β | 2007 | β |
| Opioid dependence and addiction during opioid treatment of chronic pain. | Ballantyne JC et al. | β | 2007 | β |
| Pharmacogenetic aspects of addictive behaviors. | Hejazi NS | β | 2007 | β |
| Pharmacogenetics and obstetric anesthesia. | Landau R | β | 2007 | β |
| Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. | Arbouw ME et al. | β | 2007 | β |
| Pharmacogenetics of opioids. | Somogyi AA et al. | β | 2007 | β |
| Pharmacogenomics and anaesthesia: explaining the variability in response to opiates. | Sweeney BP | β | 2007 | β |
| Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. | Kirchheiner J et al. | β | 2007 | β |
| "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. | Nelson CP et al. | β | 2007 | β |
| Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans. | van der Zwaluw CS et al. | β | 2007 | β |
| Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation. | Hernandez-Avila CA et al. | β | 2007 | β |
| The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers. | Mitchell JM et al. | β | 2007 | β |
| The opioid system in alcohol and drug dependence: family-based association study. | Xuei X et al. | β | 2007 | β |
| The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. | Kroslak T et al. | β | 2007 | β |
| Toward a rational selection of treatment for addiction. | O'Brien CP | β | 2007 | β |
| Various pharmacogenetic aspects of antiepileptic drug therapy: a review. | Mann MW et al. | β | 2007 | β |
| A conceptual model of factors influencing children's responses to a painful procedure when parents are distraction coaches. | McCarthy AM et al. | β | 2006 | β |
| Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment. | Kellogg S et al. | β | 2006 | β |
| A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. | Janicki PK et al. | β | 2006 | β |
| Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. | Bart G et al. | β | 2006 | β |
| Anger expression and pain: an overview of findings and possible mechanisms. | Bruehl S et al. | β | 2006 | β |
| Anger regulation style, postoperative pain, and relationship to the A118G mu opioid receptor gene polymorphism: a preliminary study. | Bruehl S et al. | β | 2006 | β |
| An overview of the genetics of substance use disorders. | Lachman HM | β | 2006 | β |
| Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. | Zhang H et al. | β | 2006 | β |
| Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. | Arias A et al. | β | 2006 | β |
| Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. | Nishizawa D et al. | β | 2006 | β |
| Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. | Chou WY et al. | β | 2006 | β |
| Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population. | Gallagher CJ et al. | β | 2006 | β |
| Biological research on drug abuse and addiction in Hispanics: current status and future directions. | Trujillo KA et al. | β | 2006 | β |
| Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. | Kumar R et al. | β | 2006 | β |
| Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients. | Ross JR et al. | β | 2006 | β |
| Current evidence for a genetic modulation of the response to analgesics. | LΓΆtsch J et al. | β | 2006 | β |
| Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment. | Lee AM et al. | β | 2006 | β |
| Genetic moderators of naltrexone's effects on alcohol cue reactivity. | McGeary JE et al. | β | 2006 | β |
| [Genetics, pain and analgesia]. | Stamer U et al. | β | 2006 | β |
| Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. | Strong JA et al. | β | 2006 | β |
| Hispanic drug abuse research: challenges and opportunities. | Volkow ND | β | 2006 | β |
| Individualizing analgesic prescription Part I: pharmacogenetics of opioid analgesics. | Samer CF et al. | β | 2006 | β |
| Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms. | Ide S et al. | β | 2006 | β |
| Methadone death, dosage and torsade de pointes: risk-benefit policy implications. | Latowsky M | β | 2006 | β |
| Morphine-6-glucuronide: morphine's successor for postoperative pain relief? | van Dorp EL et al. | β | 2006 | β |
| Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. | Drakenberg K et al. | β | 2006 | β |
| New findings on the genetic influences on alcohol use and dependence. | Higuchi S et al. | β | 2006 | β |
| No association of single nucleotide polymorphisms in the micro-opioid receptor subunit gene with idiopathic generalized epilepsy. | Barratt C et al. | β | 2006 | β |
| Parental history of chronic pain may be associated with impairments in endogenous opioid analgesic systems. | Bruehl S et al. | β | 2006 | β |
| Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. | Hurd YL | β | 2006 | β |
| Pharmacogenetics of opioid receptors and addiction. | Mayer P et al. | β | 2006 | β |
| Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. | Smith YR et al. | β | 2006 | β |
| Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. | LΓΆtsch J et al. | β | 2006 | β |
| Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). | Wang D et al. | β | 2006 | β |
| Sweet preference predicts mood altering effect of and impaired control over eating sweet foods. | Kampov-Polevoy AB et al. | β | 2006 | β |
| Symbiotic relationship of pharmacogenetics and drugs of abuse. | Rutter JL | β | 2006 | β |
| Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. | Oslin DW et al. | β | 2006 | β |
| The mu-opioid receptor gene and smoking initiation and nicotine dependence. | Zhang L et al. | β | 2006 | β |
| The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. | Oertel BG et al. | β | 2006 | β |
| The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. | Chong RY et al. | β | 2006 | β |
| Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. | Hansson AC et al. | β | 2006 | β |
| Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Zhang Y et al. | β | 2005 | β |
| Anticraving medications for relapse prevention: a possible new class of psychoactive medications. | O'Brien CP | β | 2005 | β |
| Are mu-opioid receptor polymorphisms important for clinical opioid therapy? | LΓΆtsch J et al. | β | 2005 | β |
| [Are polymorphisms in the mu-opioid receptor important for opioid therapy?]. | LΓΆtsch J et al. | β | 2005 | β |
| Biological clock: biological clocks may modulate drug addiction. | Yuferov V et al. | β | 2005 | β |
| Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA. | Ide S et al. | β | 2005 | β |
| Clinical response to morphine in cancer patients and genetic variation in candidate genes. | Ross JR et al. | β | 2005 | β |
| Clock reset for alcoholism. | Yuferov V et al. | β | 2005 | β |
| Deficit in beta-endorphin peptide and tendency to alcohol abuse. | Zalewska-Kaszubska J et al. | β | 2005 | β |
| Genetic determinants of addiction to opioids and cocaine. | Saxon AJ et al. | β | 2005 | β |
| Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. | Kreek MJ et al. | β | 2005 | β |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | β | 2005 | β |
| Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets. | Tang CM et al. | β | 2005 | β |
| Genetic variation in heroin-induced changes in behaviour: effects of B6 strain dose on conditioned reward and locomotor sensitization in 129-B6 hybrid mice. | Szumlinski KK et al. | β | 2005 | β |
| How individual sensitivity to opiates can be predicted by gene analyses. | Ikeda K et al. | β | 2005 | β |
| Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. | Bart G et al. | β | 2005 | β |
| Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects. | Funck-Brentano C et al. | β | 2005 | β |
| Microarray studies of psychostimulant-induced changes in gene expression. | Yuferov V et al. | β | 2005 | β |
| Morphine-6-glucuronide: actions and mechanisms. | Kilpatrick GJ et al. | β | 2005 | β |
| Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. | Smith RJ et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| Pharmacogenetics and nicotine addiction treatment. | MunafΓ² MR et al. | β | 2005 | β |
| Pharmacogenetics: implications for obstetric anesthesia. | Landau R | β | 2005 | β |
| Pharmacogenetics of anesthetic and analgesic agents. | Palmer SN et al. | β | 2005 | β |
| Pharmacotherapy and pharmacogenetics of nicotine dependence. | Berrettini WH et al. | β | 2005 | β |
| Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. | Romberg RR et al. | β | 2005 | β |
| Primate trace amine receptor 1 modulation by the dopamine transporter. | Miller GM et al. | β | 2005 | β |
| The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. | Fillingim RB et al. | β | 2005 | β |
| The contribution of genetics to addiction therapy approaches. | Edenberg HJ et al. | β | 2005 | β |
| Treating tobacco dependence: state of the science and new directions. | Lerman C et al. | β | 2005 | β |
| Alcoholism: genes and mechanisms. | Oroszi G et al. | β | 2004 | β |
| A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. | Miller GM et al. | β | 2004 | β |
| A possible genetic mechanism underlying individual and interstrain differences in opioid actions: focus on the mu opioid receptor gene. | Han W et al. | β | 2004 | β |
| Association of functional opioid receptor genotypes with alcohol dependence in Koreans. | Kim SG et al. | β | 2004 | β |
| Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients. | Kim SA et al. | β | 2004 | β |
| Comprehensive mu-opioid-receptor genotyping by pyrosequencing. | Skarke C et al. | β | 2004 | β |
| Differential expression of mu-opioid receptor gene in CXBK and B6 mice by Sp1. | Lee PW et al. | β | 2004 | β |
| Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. | Beyer A et al. | β | 2004 | β |
| Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | Loh el W et al. | β | 2004 | β |
| Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA. | Kreek MJ et al. | β | 2004 | β |
| Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. | Bolan EA et al. | β | 2004 | β |
| Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. | Ide S et al. | β | 2004 | β |
| Genes associated with addiction: alcoholism, opiate, and cocaine addiction. | Kreek MJ et al. | β | 2004 | β |
| Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. | LΓΆtsch J et al. | β | 2004 | β |
| Genetic variation and pharmacogenomics: concepts, facts, and challenges. | Hoehe MR et al. | β | 2004 | β |
| Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. | Urraca N et al. | β | 2004 | β |
| Mutant G-protein-coupled receptors as a cause of human diseases. | SchΓΆneberg T et al. | β | 2004 | β |
| Opioids and alcoholism. | Oswald LM et al. | β | 2004 | β |
| Post-transcriptional regulation of opioid receptors in the nervous system. | Wei LN et al. | β | 2004 | β |
| Principles of pharmacogenetics--implications for the anaesthetist. | Iohom G et al. | β | 2004 | β |
| Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. | Bart G et al. | β | 2004 | β |
| The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. | Lerman C et al. | β | 2004 | β |
| Watson and Crick 50 years on. From double helix to pharmacogenomics. | Sweeney BP | β | 2004 | β |
| A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. | Oslin DW et al. | β | 2003 | β |
| Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. | Compton P et al. | β | 2003 | β |
| Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). | Hernandez-Avila CA et al. | β | 2003 | β |
| Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. | Schluger JH et al. | β | 2003 | β |
| Do genes influence outcome from anaesthesia? | Sweeney BP | β | 2003 | β |
| Drug dependence and the endogenous opioid system. | Gerrits MA et al. | β | 2003 | β |
| Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. | Luo X et al. | β | 2003 | β |
| Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence. | Franke P et al. | β | 2003 | β |
| Neuropeptide gene polymorphisms and human behavioural disorders. | Inui A | β | 2003 | β |
| Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. | Hirota T et al. | β | 2003 | β |
| Variants of kappa-opioid receptor gene and mRNA in alcohol-preferring and alcohol-avoiding mice. | Saito M et al. | β | 2003 | β |
| A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. | Schinka JA et al. | β | 2002 | β |
| A polymorphism (A118G) in the mu-opioid receptor gene affects the response to morphine-6-glucuronide in humans. | HΓΆllt V | β | 2002 | β |
| Association of mu-opioid receptor subunit gene and idiopathic generalized epilepsy. | Wilkie H et al. | β | 2002 | β |
| Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants. | Xin L et al. | β | 2002 | β |
| Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. | Eap CB et al. | β | 2002 | β |
| Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children. | Jorm AF et al. | β | 2002 | β |
| Opioid receptor polymorphisms and opioid abuse. | Lee NM et al. | β | 2002 | β |
| p21 gene codon 31 polymorphism is associated with bladder cancer. | Chen WC et al. | β | 2002 | β |
| Pharmacotherapy of addictions. | Kreek MJ et al. | β | 2002 | β |
| Receptor pharmacogenetics: relevance to CNS syndromes. | Shaikh S et al. | β | 2002 | β |
| Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. | Xu K et al. | β | 2002 | β |
| Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese. | Su ZG et al. | β | 2002 | β |
| The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity. | Trujillo KA | β | 2002 | β |
| The Personality Assessment Inventory Drug Problems Scale: a validity analysis. | Kellogg SH et al. | β | 2002 | β |
| The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. | LΓΆtsch J et al. | β | 2002 | β |
| Allelic and somatic variations in the endogenous opioid system of humans. | Mayer P et al. | β | 2001 | β |
| A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. | GrΓΆsch S et al. | β | 2001 | β |
| A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. | Befort K et al. | β | 2001 | β |
| Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. | Szeto CY et al. | β | 2001 | β |
| Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals. | Rommelspacher H et al. | β | 2001 | β |
| Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. | Rana BK et al. | β | 2001 | β |
| Genetic variations in human G protein-coupled receptors: implications for drug therapy. | Sadee W et al. | β | 2001 | β |
| Morphine-6-glucuronide: an analgesic of the future? | LΓΆtsch J et al. | β | 2001 | β |
| Morphine tolerance in mice is independent of polymorphisms in opioid receptor sequences. | Gant TM et al. | β | 2001 | β |
| Neuroimaging in alcoholism: ethanol and brain damage. | Mann K et al. | β | 2001 | β |
| Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. | Franke P et al. | β | 2001 | β |
| No pain relief from codeine...? An introduction to pharmacogenomics. | Fagerlund TH et al. | β | 2001 | β |
| Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence. | Cigler T et al. | β | 2001 | β |
| Pharmacogenomics: implications for laboratory medicine. | Schmitz G et al. | β | 2001 | β |
| Polymorphisms of mu and delta opioid receptor genes and tardive dyskinesia in patients with schizophrenia. | Ohmori O et al. | β | 2001 | β |
| Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. | Chavkin C et al. | β | 2001 | β |
| Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding. | Wang D et al. | β | 2001 | β |
| The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice. | Ikeda K et al. | β | 2001 | β |
| Association analysis of polymorphisms in the ΞΌ opioid gene and heroin abuse in Chinese subjects. | Li T et al. | β | 2000 | β |
| Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction. | LaForge KS et al. | β | 2000 | β |
| Genetics of alcohol withdrawal. | Schmidt LG et al. | β | 2000 | β |
| Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy. | Sander T et al. | β | 2000 | β |
| Genetic vulnerability to drug abuse. | Duaux E et al. | β | 2000 | β |
| Genome polymorphism and alcoholism. | Thome J et al. | β | 2000 | β |
| Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. | Kreek MJ | β | 2000 | β |
| Molecular mechanisms and regulation of opioid receptor signaling. | Law PY et al. | β | 2000 | β |
| Opioid receptor and peptide gene polymorphisms: potential implications for addictions. | LaForge KS et al. | β | 2000 | β |
| Pain responses in methadone-maintained opioid abusers. | Compton P et al. | β | 2000 | β |
| Pharmacogenomics and addiction to opiates. | Lichtermann D et al. | β | 2000 | β |
| Pharmacogenomics: the genomics of drug response. | March R | β | 2000 | β |
| The opioid receptor system and alcoholism: a genetic perspective. | Town T et al. | β | 2000 | β |
| Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. | Town T et al. | β | 1999 | β |
| Endogenous opiates: 1998. | Vaccarino AL et al. | β | 1999 | β |
| mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. | Smolka M et al. | β | 1999 | β |
| Solution structure of human beta-endorphin in helicogenic solvents: an NMR study. | Saviano G et al. | β | 1999 | β |
| The genetic mediation of individual differences in sensitivity to pain and its inhibition. | Mogil JS | β | 1999 | β |
| The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. | Uhl GR et al. | β | 1999 | β |